Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology.
Eklöf AC, Thurelius AM, Garle M, Rane A, Sjöqvist F. Eklöf AC, et al. Among authors: garle m. Eur J Clin Pharmacol. 2003 Nov;59(8-9):571-7. doi: 10.1007/s00228-003-0633-z. Epub 2003 Sep 12. Eur J Clin Pharmacol. 2003. PMID: 13680032
[Anabolic androgenic steroids are more common in society than in sports].
Christakopoulos A, Ericsson M, Garle M, Villén T, Beck O. Christakopoulos A, et al. Among authors: garle m. Lakartidningen. 2013 Sep 25-Oct 8;110(39-40):1732-4. Lakartidningen. 2013. PMID: 24245428 Review. Swedish. No abstract available.
Anabolic androgenic steroids in police cases in Sweden 1999-2009.
Lood Y, Eklund A, Garle M, Ahlner J. Lood Y, et al. Among authors: garle m. Forensic Sci Int. 2012 Jun 10;219(1-3):199-204. doi: 10.1016/j.forsciint.2012.01.004. Epub 2012 Jan 23. Forensic Sci Int. 2012. PMID: 22269132
Anabolic steroids and cardiovascular risk: A national population-based cohort study.
Thiblin I, Garmo H, Garle M, Holmberg L, Byberg L, Michaëlsson K, Gedeborg R. Thiblin I, et al. Among authors: garle m. Drug Alcohol Depend. 2015 Jul 1;152:87-92. doi: 10.1016/j.drugalcdep.2015.04.013. Epub 2015 May 11. Drug Alcohol Depend. 2015. PMID: 26005042
Use of doping agents, particularly anabolic steroids, in sports and society.
Sjöqvist F, Garle M, Rane A. Sjöqvist F, et al. Among authors: garle m. Lancet. 2008 May 31;371(9627):1872-82. doi: 10.1016/S0140-6736(08)60801-6. Lancet. 2008. PMID: 18514731 Review.
Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes.
Ekström L, Cevenini L, Michelini E, Schulze J, Thörngren JO, Belanger A, Guillemette C, Garle M, Roda A, Rane A. Ekström L, et al. Among authors: garle m. Eur J Clin Invest. 2013 Mar;43(3):248-55. doi: 10.1111/eci.12037. Epub 2013 Jan 7. Eur J Clin Invest. 2013. PMID: 23294483
Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests.
Schulze JJ, Lundmark J, Garle M, Ekström L, Sottas PE, Rane A. Schulze JJ, et al. Among authors: garle m. Steroids. 2009 Mar;74(3):365-8. doi: 10.1016/j.steroids.2008.11.003. Epub 2008 Nov 13. Steroids. 2009. PMID: 19056415
Criminality among individuals testing positive for the presence of anabolic androgenic steroids.
Klötz F, Garle M, Granath F, Thiblin I. Klötz F, et al. Among authors: garle m. Arch Gen Psychiatry. 2006 Nov;63(11):1274-9. doi: 10.1001/archpsyc.63.11.1274. Arch Gen Psychiatry. 2006. PMID: 17088508
Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids.
Petersson A, Garle M, Holmgren P, Druid H, Krantz P, Thiblin I. Petersson A, et al. Among authors: garle m. Drug Alcohol Depend. 2006 Feb 28;81(3):241-9. doi: 10.1016/j.drugalcdep.2005.07.003. Epub 2005 Aug 30. Drug Alcohol Depend. 2006. PMID: 16137840
Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care. A controlled retrospective cohort study.
Petersson A, Garle M, Granath F, Thiblin I. Petersson A, et al. Among authors: garle m. Drug Alcohol Depend. 2006 Feb 28;81(3):215-20. doi: 10.1016/j.drugalcdep.2005.07.001. Epub 2005 Aug 24. Drug Alcohol Depend. 2006. PMID: 16125336
101 results
Jump to page
Feedback